Merit Medical Systems Pre-Paid Expenses 2010-2024 | MMSI

Merit Medical Systems pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Merit Medical Systems pre-paid expenses for the quarter ending September 30, 2024 were $0.027B, a 3.04% decline year-over-year.
  • Merit Medical Systems pre-paid expenses for 2023 were $0.024B, a 8.79% increase from 2022.
  • Merit Medical Systems pre-paid expenses for 2022 were $0.022B, a 38.24% increase from 2021.
  • Merit Medical Systems pre-paid expenses for 2021 were $0.016B, a 23.09% increase from 2020.
Merit Medical Systems Annual Pre-Paid Expenses
(Millions of US $)
2023 $24
2022 $22
2021 $16
2020 $13
2019 $12
2018 $11
2017 $9
2016 $6
2015 $6
2014 $5
2013 $5
2012 $4
2011 $4
2010 $2
2009 $1
Merit Medical Systems Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $27
2024-06-30 $26
2024-03-31 $24
2023-12-31 $24
2023-09-30 $28
2023-06-30 $25
2023-03-31 $20
2022-12-31 $22
2022-09-30 $27
2022-06-30 $23
2022-03-31 $20
2021-12-31 $16
2021-09-30 $19
2021-06-30 $17
2021-03-31 $14
2020-12-31 $13
2020-09-30 $16
2020-06-30 $14
2020-03-31 $16
2019-12-31 $12
2019-09-30 $18
2019-06-30 $12
2019-03-31 $11
2018-12-31 $11
2018-09-30 $12
2018-06-30 $12
2018-03-31 $10
2017-12-31 $9
2017-09-30 $21
2017-06-30 $9
2017-03-31 $8
2016-12-31 $6
2016-09-30 $7
2016-06-30 $8
2016-03-31 $6
2015-12-31 $6
2015-09-30 $5
2015-06-30 $6
2015-03-31 $5
2014-12-31 $5
2014-09-30 $6
2014-06-30 $5
2014-03-31 $6
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $5
2012-12-31 $4
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $4
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $2
2010-09-30 $3
2010-06-30 $3
2010-03-31 $2
2009-12-31 $1
2009-09-30 $2
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.067B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74